These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of re-utilization of cuprophan capillary dialysers with different liquids on their biocompatibility and effectiveness of elimination]. Orłowski A; Szepietowski T Polim Med; 1992; 22(1-2):59-72. PubMed ID: 1461837 [TBL] [Abstract][Full Text] [Related]
4. Biocompatibility aspects of dialyzer reprocessing: a comparison of 3 re-use methods and 3 membranes. Kuwahara T; Markert M; Wauters JP Clin Nephrol; 1989 Sep; 32(3):139-43. PubMed ID: 2791365 [TBL] [Abstract][Full Text] [Related]
5. Research on dialyzers with improved biocompatibility. van der Steen A Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466 [TBL] [Abstract][Full Text] [Related]
6. Does an alteration of dialyzer design and geometry affect biocompatibility parameters? Opatrný K; Krouzzecký A; Polanská K; Mares J; Tomsů M; Bowry SK; Vienken J Hemodial Int; 2006 Apr; 10(2):201-8. PubMed ID: 16623675 [TBL] [Abstract][Full Text] [Related]
7. [Experience with the multiple use of dialyzers]. Strokov AG; Poz IaL; Baeva LB; Levitskiĭ ER; Annenkov AE; Rud'ko IA; Kubatiev AA Ter Arkh; 1994; 66(6):60-5. PubMed ID: 7940372 [TBL] [Abstract][Full Text] [Related]
8. [Interaction between blood and dialysis membrane]. Szepietowski T; Orłowski A Polim Med; 1991; 21(3-4):3-13. PubMed ID: 1822594 [TBL] [Abstract][Full Text] [Related]
10. The influence of cuprophan and polysulfone membranes on dialyzer reusability and intradialytic complications. Kadiri S; Kehinde Z; Arije A; Salako BL Afr J Med Med Sci; 2001 Sep; 30(3):191-4. PubMed ID: 14510127 [TBL] [Abstract][Full Text] [Related]
11. Dialyzer reprocessing with peroxyacetic acid as sole cleansing and sterilizing agent. Kes P; Reiner Z; Ratković-Gusić I Acta Med Croatica; 1997; 51(2):87-93. PubMed ID: 9204593 [TBL] [Abstract][Full Text] [Related]
12. Effect of dialyzer reuse on survival of patients treated with hemodialysis. Feldman HI; Kinosian M; Bilker WB; Simmons C; Holmes JH; Pauly MV; Escarce JJ JAMA; 1996 Aug; 276(8):620-5. PubMed ID: 8773634 [TBL] [Abstract][Full Text] [Related]
13. Biocompatibility of hemodialysis membranes: evaluation in an ovine model. Burhop KE; Johnson RJ; Simpson J; Chenoweth DE; Borgia J J Lab Clin Med; 1993 Feb; 121(2):276-93. PubMed ID: 8433041 [TBL] [Abstract][Full Text] [Related]
14. A new synthetic dialyzer with advanced permselectivity for enhanced low-molecular weight protein removal. Krieter DH; Lemke HD; Wanner C Artif Organs; 2008 Jul; 32(7):547-54. PubMed ID: 18638309 [TBL] [Abstract][Full Text] [Related]
15. The influence of dialyzer geometry on blood coagulation and biocompatibility. Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717 [TBL] [Abstract][Full Text] [Related]
17. [Changes in leukocyte counts using a cellulose acetate membrane (FB-T) during hemodialysis. A comparison with a cuprophane membrane]. Pak K; Kobira S; Tomoyoshi T; Nishimura N Hinyokika Kiyo; 1986 Sep; 32(9):1231-5. PubMed ID: 3812143 [TBL] [Abstract][Full Text] [Related]
18. [The effect of the primary and repeated use of dialyzers with different membranes on the degree of dialysis-induced leukopenia]. Strokov AG; Baeva LB; Levitskiĭ ER Med Tekh; 1990; (5):16-8. PubMed ID: 2273963 [TBL] [Abstract][Full Text] [Related]